Skip to main content
. 2017 Mar 13;56(11):1355–1368. doi: 10.1007/s40262-017-0526-4

Fig. 6.

Fig. 6

Typical concentration–time profile (and 5th–95th percentile interval of individual predicted profiles) during the first two treatment cycles following oral dosing of ixazomib capsules at 4 mg on days 1, 8 and 15 of 28-day treatment cycles, based on a typical patient (body surface area = 1.88 m2)